Metraipolis › archive › dc_8ec667f8cd08

Dual roles of immunosenescence in cancer immunotherapy — Europe PMC PMID:41869357

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41869357
DOI
10.3389/fimmu.2026.1779141
License (as archived)
solo-consultazione
Archived
2026-11-05T01:00:52.418Z
SHA-256 of the archived text
f0be6dd9a387c49b139865df92b5b9489c2e6a303adf24e94e59af61801371aa
Stable URL of this page
https://metraipolis.com/documento/dc_8ec667f8cd08

How to cite

Dual roles of immunosenescence in cancer immunotherapy — Europe PMC PMID:41869357 — Europe PMC (en), https://europepmc.org/article/MED/41869357 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8ec667f8cd08 (Metraipolis archive dc_8ec667f8cd08, sha256 f0be6dd9a387c49b139865df92b5b9489c2e6a303adf24e94e59af61801371aa)
BibTeX
@misc{dc8ec667f8cd08,
  title = {Dual roles of immunosenescence in cancer immunotherapy — Europe PMC PMID:41869357},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41869357},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8ec667f8cd08; sha256 f0be6dd9a387c49b139865df92b5b9489c2e6a303adf24e94e59af61801371aa},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41869357. Agents can read the archived copy with the MCP tool read_document.